Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Appointed director
Inv. presentation
Director departure
MedAvail Holdings, Inc. (MDVL) Create: Alert

All | News | Filings
Date FiledTypeDescription
08/18/2023 8-K Quarterly results
08/14/2023 10-Q Quarterly Report for the period ended June 30, 2023
08/14/2023 8-K Investor presentation, Quarterly results
Docs: "MedAvail Reports Second Quarter 2023 Financial Results",
"Q2 2023 Letter to Stockholders August 14, 2023 Page 1 of 9 Legal Disclaimer Certain",
"INVESTOR PRESENTATION"
07/31/2023 8-K Quarterly results
07/20/2023 EFFECT Form EFFECT - Notice of Effectiveness:
07/14/2023 S-3/A Form S-3/A - Registration statement under Securities Act of 1933: [Amend]
06/29/2023 S-8 Form S-8 - Securities to be offered to employees in employee benefit plans:
06/29/2023 S-3 Form S-3 - Registration statement under Securities Act of 1933:
06/29/2023 8-K Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "PWC CONSENT",
"BT CONSENT",
"This Exhibit 99.1 to"
06/16/2023 8-K Changes in Registrant's Certifying Accountant, Submission of Matters to a Vote of Security Holders, Other Events &...
05/19/2023 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
05/18/2023 10-Q Quarterly Report for the period ended March 31, 2023
05/18/2023 8-K Quarterly results
Docs: "MedAvail Reports First Quarter 2023 Financial Results"
05/08/2023 8-K Changes in Registrant's Certifying Accountant, Financial Statements and Exhibits  Interactive Data
05/04/2023 8-K Quarterly results
05/01/2023 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
05/01/2023 DEF 14A Form DEF 14A - Other definitive proxy statements:
04/17/2023 PRE 14A Form PRE 14A - Other preliminary proxy statements:
04/17/2023 8-K Quarterly results
04/14/2023 10-K Annual Report for the period ended December 31, 2022
04/13/2023 8-K Results of Operations and Financial Condition, Regulation FD Disclosure  Interactive Data
Docs: "MedAvail Reports Fourth Quarter and Full-Year 2022 Financial Results"
04/06/2023 8-K/A Completion of Acquisition or Disposition of Assets, Financial Statements and Exhibits  Interactive Data
Docs: "MedAvail Holdings, Inc. Summary of Unaudited Pro Forma Condensed Consolidated Financial Information"
04/03/2023 8-K Entry into a Material Definitive Agreement, Financial Statements and Exhibits  Interactive Data
Docs: "Letter Agreement"
03/31/2023 NT 10-K Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405:
03/15/2023 SC 13D/A Ally Bridge Group-WTT Global Life Science Capital Partners, L.P. reports a 29.6% stake in MedAvail Holdings, Inc.
03/14/2023 8-K Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Other Events, Financial Statements and E...
Docs: "SECURITIES PURCHASE AGREEMENT",
"REGISTRATION RIGHTS AGREEMENT",
"MEDAVAIL HOLDINGS, INC. PRE-FUNDED WARRANT TO PURCHASE COMMON STOCK",
"MEDAVAIL HOLDINGS, INC. SERIES A WARRANT TO PURCHASE COMMON STOCK",
"MedAvail Announces Closing of $16 Million Private Placement"
02/14/2023 SC 13G Alyeska Investment Group, L.P. reports a 10% stake in MEDAVAIL HOLDINGS, INC.
02/10/2023 8-K Quarterly results
01/26/2023 8-K Entry into a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Results of Operations and Fin...
Docs: "MedAvail announces Sale of Pharmacy Assets to CVS Pharmacy"
01/19/2023 8-K Quarterly results
12/06/2022 8-K Quarterly results
11/10/2022 10-Q Quarterly Report for the period ended September 30, 2022
11/10/2022 8-K Quarterly results
11/04/2022 8-K Quarterly results
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy